In vitro and in vivo evaluation of possible pro-survival activities of PGE2, EGF, TPO and FLT3L on human hematopoiesis

Myelosuppression is a major and frequently dose-limiting side effect of anticancer therapy and is responsible for most treatment-related morbidity and mortality. In addition, repeated cycles of DNA damage and cell death of hematopoietic stem and progenitor cells, followed by compensatory proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Demmerath, Eva-Maria, Bohler, Sheila, Kunze, Mirjam, Erlacher, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442978/
https://www.ncbi.nlm.nih.gov/pubmed/30442724
http://dx.doi.org/10.3324/haematol.2018.191569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442978/
https://www.ncbi.nlm.nih.gov/pubmed/30442724
http://dx.doi.org/10.3324/haematol.2018.191569

Ejemplares similares